Direct‐to‐Consumer Genetic Testing for Health‐Related Purposes in the European Union Summary of points from a meeting organised by EASAC, FEAM and STOA in the European Parliament

First Page		Document Content
Date: 2013-01-25 04:17:26 Medical genetics Genetic testing Pharmacology United States Public Health Service Science and Technology Options Assessment Medical device Food and Drug Administration Predictive medicine Direct-to-consumer advertising Medicine Health Medical ethics		Direct‐to‐Consumer Genetic Testing for Health‐Related Purposes in the European Union Summary of points from a meeting organised by EASAC, FEAM and STOA in the European Parliament Add to Reading List Source URL: www.easac.eu Download Document from Source Website File Size: 445,04 KB Share Document on Facebook

	Technology and Policy Options for a Low-Emission Energy System in Canada The Expert Panel on Energy Use and Climate Change Science Advice in the Public Interest DocID: 1q90o - View Document
	Directorate for Impact Assessment and European Added Value DocID: 1pQ5t - View Document
	Technology and Policy Options for a Low-Emission Energy System in Canada The Expert Panel on Energy Use and Climate Change Science Advice in the Public Interest DocID: 1pCw1 - View Document
	Briefing European Parliamentary Research Service DocID: 1pmz9 - View Document
	In this issue: ANNUAL LECTURE SCIENCE AND TECHNOLOGY OPTIONS ASSESSMENT NEWSLETTER DocID: 1p5WG - View Document